About this project
TThe global outbreak of the coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents a serious threat to public health. Probiotics are living microorganisms which confer health benefits to the host, and they have shown positive effects on antibody responses following certain vaccinations against other viruses. One of these probiotics, Limosilactobacillus reuteri, has shown to be able to decrease the number of sick leave days during influenza season as well as increase the production of certain antibodies.
The aim of this project is to examine the effect of daily probiotic supplementation on antibody response against SARS-CoV-2